Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND for phase I trials of ImmuneOncia's IMC-002

April 23, 2020

Investigator-initiated trial to study Insmed's brensocatib for severe COVID-19

April 23, 2020

Amryt closes enrollment in phase III EASE trial of AP-101 for epidermolysis bullosa

April 23, 2020

Oncorus enrolling in first-in-human trial of oncolytic immunotherapy ONCR-177

April 23, 2020

FDA approves Trodelvy for previously treated metastatic TNBC

April 23, 2020

New HBV HBeAg and HBsAg secretion inhibitors presented by Roche

April 23, 2020

Medshine Discovery identifies AOC3 inhibitors

April 23, 2020

iTeos Therapeutics presents adenosine A2A receptor antagonists

April 23, 2020

Antabio SAS divulges Pseudomonas aeruginosa elastase inhibitors

April 23, 2020

Takeda Pharmaceutical discloses new GIPR agonists

April 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...